Nuveen
BSX icon

Nuveen’s Boston Scientific BSX Stock Holding History

Nuveen’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-51,000
Closed -$2K – 3297
2020
Q2 		$2K Hold
51,000
– – ﹤0.01% 3250
2020
Q1 		$2K Buy
+51,000
New +$1.99M ﹤0.01% 3187

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen's BSX Position: Q2 2026 in Review

Nuveen reduced its Boston Scientific (BSX) stake by 26% in Q2 2026, selling an estimated $165M and leaving 8,695,119 shares worth $371M. The position accounts for 0.09% of the portfolio, ranked #174.

Nuveen first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.02B in Q2 2025. 1,485 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Nuveen held 8,695,119 shares of Boston Scientific worth $371M as of Q2 2026.
  • Nuveen sold 3,039,195 Boston Scientific shares in Q2 2026, an estimated $165M.
  • Boston Scientific made up 0.09% of Nuveen's portfolio in Q2 2026, its #174 holding.
  • Nuveen first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's Boston Scientific position peaked at $1.02B in Q2 2025.
  • 1,485 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.